Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
12/20/2000 | CN1059557C A medical preparation containing goose egg for treating osteoproliferation |
12/20/2000 | CN1059556C Compound cinobufogin |
12/20/2000 | CN1059555C Preparation for compound sodium fulvate injecta |
12/19/2000 | US6162796 Method for transferring genes to the heart using AAV vectors |
12/19/2000 | US6162643 Serum-free mixture of 2-(4-(2-hydroxyethyl)piperazinyl) ethanesulfonic acid at concentration of 16-22 mm, sodium chloride at 90-140 mm, and a protease; for production of epithelial tissues like epidermis, cornea, gingiva and ureter |
12/19/2000 | US6162600 Indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
12/19/2000 | US6162428 hNT-neuron human neuronal cells to replace ganglion cells |
12/14/2000 | WO2000075365A2 Compounds and methods to enhance raav transduction |
12/14/2000 | WO2000075351A1 Siv-based packaging-defficient vectors |
12/14/2000 | WO2000075347A2 Tet repressor-based transcriptional regulatory proteins |
12/14/2000 | WO2000075334A1 Apoptosis inhibition by adenovirus e3/6.7k |
12/14/2000 | WO2000075292A1 Herpes simplex virus expressing foreign genes and method for treating cancers therewith |
12/14/2000 | WO2000075291A2 Cells with enforced expression of bcl-xl |
12/14/2000 | WO2000075290A1 Method for multiplying stem cells |
12/14/2000 | WO2000075284A1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use |
12/14/2000 | WO2000075275A2 Bioreactor design and process for engineering tissue from cells |
12/14/2000 | WO2000075187A1 An integrin heterodimer and an alpha subunit thereof |
12/14/2000 | WO2000075183A1 Product from starfish |
12/14/2000 | WO2000074741A2 Biological joint construct |
12/14/2000 | WO2000074729A2 Alpha or beta emitters to fragments in radioimmunotherapy |
12/14/2000 | WO2000074722A2 Modification of biological elements |
12/14/2000 | WO2000074715A1 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
12/14/2000 | WO2000074713A1 Autologous thrombin |
12/14/2000 | WO2000074712A2 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
12/14/2000 | WO2000074693A2 Immunity generation |
12/14/2000 | WO2000074692A1 A method using potassium dihydrogen phosphate to reduce calcification of tissue |
12/14/2000 | WO2000074690A1 Bone graft substitute composition |
12/14/2000 | WO2000074629A2 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal |
12/14/2000 | WO2000074584A1 Devices and methods for treating tissue |
12/14/2000 | WO2000074483A1 Improved storage and maintenance of blood products including red blood cells and platelets |
12/14/2000 | WO2000074478A1 Method and device for rearing insects, especially for obtaining a secretion from fly larvae for therapeutic application |
12/14/2000 | WO2000050570A3 Compositions and methods for modulating growth or differentiation of growth-factor dependent cells |
12/14/2000 | WO2000049141A3 A method for production and delivery of a protein in vivo |
12/14/2000 | WO2000048624A3 Utilization of orosomucoid in order to produce a pharmaceutical preparation |
12/14/2000 | WO2000048615A3 TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE) |
12/14/2000 | WO2000047229A3 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules |
12/14/2000 | WO2000043498A3 Human liver progenitors |
12/14/2000 | WO2000042063A3 Peptides for inhibiting hbv core proteins |
12/14/2000 | WO2000039135A3 Insulin mimetics from honey |
12/14/2000 | WO2000015264A9 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression |
12/14/2000 | DE19926083A1 Biologisches Gelenkkonstrukt The biological joint construct |
12/14/2000 | DE19926074A1 Therapeutic solution, especially for cancer treatment, obtained by heating and pulverizing tumor tissue and dissolving product in aqueous solution |
12/14/2000 | DE19925996A1 Verfahren und Vorrichtung zur Herstellung des Sekrets von Fliegenlarven für die therapeutische Applikation Method and apparatus for the production of the secretion of the fly larvae for therapeutic application |
12/14/2000 | DE10025867A1 Increasing performance-related activity, reducing general inactivity and improving general health, using kombucha as alpha-rhythm modulator |
12/14/2000 | CA2376939A1 Herpes simplex virus expressing foreign genes and method for treating cancers therewith |
12/14/2000 | CA2376790A1 Siv-based packaging-defficient vectors |
12/14/2000 | CA2376665A1 Novel tet repressor-based transcriptional regulatory proteins |
12/14/2000 | CA2376400A1 Compounds and methods to enhance raav transduction |
12/14/2000 | CA2376314A1 Apoptosis inhibition by adenovirus e3/6.7k |
12/14/2000 | CA2376048A1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
12/14/2000 | CA2376039A1 Bioreactor design and process for engineering tissue from cells |
12/14/2000 | CA2375876A1 An integrin heterodimer and an alpha subunit thereof |
12/14/2000 | CA2375485A1 Method for multiplying stem cells |
12/14/2000 | CA2374256A1 Methods and compounds for the treatment of immunologically-mediated diseases using <i>mycobacterium vaccae</i> |
12/14/2000 | CA2374001A1 Alpha or beta emitters attached to fragments in radioimmunotherapy |
12/14/2000 | CA2373277A1 Immunity generation |
12/14/2000 | CA2339900A1 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal |
12/13/2000 | EP1058725A1 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
12/13/2000 | EP1058563A1 Systems and methods for obtaining a uniform targeted volume of concentrated red blood cells |
12/13/2000 | EP1058555A1 Costimulatory blockade and mixed chimerism in allotransplantation |
12/13/2000 | EP1058554A2 Nontoxic vernix compositions and method of producing |
12/13/2000 | EP0927196A4 Polymers containing polysaccharides such as alginates or modified alginates |
12/13/2000 | EP0601062B2 Sirs vaccine and diagnosis method |
12/13/2000 | CN1276834A Modified nucleic acid sequences and method for increasing mRNA level and protein expression in cell system |
12/13/2000 | CN1276831A Modified nucleic acid sequences and method for increasing mRNA levels and protein expression in cell systems |
12/13/2000 | CN1276725A Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma |
12/13/2000 | CN1276242A Chinese medicine for curing cough and asthma |
12/13/2000 | CN1276239A Anticancer pill and its preparing process |
12/13/2000 | CN1276234A Medicine for treating rheumatism, rheumatoid disease, hyperosteogeny and arthritis, and its preparing process |
12/13/2000 | CN1276227A Process for preparing Chinese medicine preparation of treating pyelonephritis |
12/13/2000 | CN1276226A Plaster for treating cancer and tumor |
12/13/2000 | CN1276225A 'Chanhoukang' for postpartum recovery and its preparing process |
12/13/2000 | CN1276223A Bone setting capsule and its preparing process |
12/13/2000 | CN1276221A Anal fissure ointment and its preparing process |
12/13/2000 | CN1276220A Chinese-medicinal capsule for preventing and treating cerebral apoplexy |
12/13/2000 | CN1276213A Medicine for treating diseases in chicken respiratory tract |
12/13/2000 | CN1059466C Method for identifying individuals suffering from cellular abnormality |
12/13/2000 | CN1059465C Method for diagnosing disorder by determining expression of GAGE tumor rejection antigen precursors |
12/13/2000 | CN1059346C Chinese herb medicine for external use of gynecopathy |
12/13/2000 | CN1059344C Health medicinal liquor and preparation method thereof |
12/13/2000 | CN1059339C Chinese medicine for treatment of migraine and method for preparing same |
12/13/2000 | CN1059338C Chinese medicine for treating cerebral vascular diseases and its producing method |
12/13/2000 | CN1059333C Chinese patent drug for various cancers and tumors |
12/13/2000 | CN1059325C Health-care beer |
12/13/2000 | CN1059324C Bones and tendon recovery cream |
12/12/2000 | US6160093 Microorganism polypeptide; for the prevention, treatment and diagnosis of microorganismal infection; for use in immunotherapy; anticarcinogenic agents |
12/12/2000 | US6160087 Peptides having an amino acid sequence from the fimbrial protein of porphyromonas gingivalis and their uses |
12/12/2000 | US6159701 Imaging tumor cells in vivo by obtaining sample of monocytes, macrophages, or splenocytes; priming the cells; labeling with radiolabelled a1 adenosine receptor agonist which induces cytotoxicity in the cells; administering to patient |
12/12/2000 | US6159504 Producing, by electrostatic attraction, micro calcium-containing shells on the surfaces of droplets of an emulsion comprising oil; replacing oil with other solvent, drying, introducing core substance into the hollow |
12/12/2000 | US6159500 Pharmaceutical preparations of glutathione and methods of administration thereof |
12/12/2000 | US6159495 Used as a wound dressing, a tissue-engineering scaffold, a diffusion membrane, a coating for implantable devices, a cell encapsulant, and a cross-linked implantable biomaterial for soft and hard tissue replacement |
12/12/2000 | US6159465 Epithelial adhesive lactobacilli |
12/12/2000 | US6159461 Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells |
12/12/2000 | US6159443 X-ray guided drug delivery |
12/09/2000 | CA2308691A1 Live attenuated bacteria for use in a vaccine |
12/07/2000 | WO2000073801A2 Breast, gastric and prostate cancer associated antigens and uses therefor |
12/07/2000 | WO2000073764A2 Composition and methods for the therapeutic use of an atonal-associated sequence |
12/07/2000 | WO2000073482A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
12/07/2000 | WO2000073481A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in the tnf-associated disorders |
12/07/2000 | WO2000073480A1 Compositions and methods for production of recombinant virus using a carrier vector derived from a nonmammalian virus |